摘要 |
The present invention relates to a compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. The present invention also provides a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound. |
申请人 |
GREEN CROSS CORPORATION;CHOI, SOONGYU;SONG, KWANG-SEOP;LEE, SUK HO;KIM, MIN JU;SEO, HEE JEONG;PARK, EUN-JUNG;KONG, YOUNGGYU;PARK, SO OK;KANG, HYUNKU;JUNG, MYUNG EUN;LEE, KINAM;KIM, HYUN JUNG;LEE, JUN SUNG;LEE, MIN WOO;KIM, MI-SOON;HONG, DONG HO;KANG, MISUK |
发明人 |
CHOI, SOONGYU;SONG, KWANG-SEOP;LEE, SUK HO;KIM, MIN JU;SEO, HEE JEONG;PARK, EUN-JUNG;KONG, YOUNGGYU;PARK, SO OK;KANG, HYUNKU;JUNG, MYUNG EUN;LEE, KINAM;KIM, HYUN JUNG;LEE, JUN SUNG;LEE, MIN WOO;KIM, MI-SOON;HONG, DONG HO;KANG, MISUK |